10.6084/m9.figshare.4467848.v1
Cédric Bretonnière
Cédric
Bretonnière
Mathieu Jozwiak
Mathieu
Jozwiak
Christophe Girault
Christophe
Girault
Pascal Beuret
Pascal
Beuret
Jean-Louis Trouillet
Jean-Louis
Trouillet
Nadia Anguel
Nadia
Anguel
Jocelyne Caillon
Jocelyne
Caillon
Gilles Potel
Gilles
Potel
Daniel Villers
Daniel
Villers
David Boutoille
David
Boutoille
Christophe Guitton
Christophe
Guitton
Additional file 1: Figure S1. of Rifampin use in acute community-acquired meningitis in intensive care units: the French retrospective cohort ACAM-ICU study
Springer Nature
2015
Table S 1. Comparison
French retrospective cohort ACAM-ICU study Bacteria
pneumococcal meningitis
Figure S 2. Glasgow Outcome Scale scores
Figure S 3. Glasgow Outcome Scale scores
community-acquired meningitis
ICU admission
PDF 157 kb
2015-08-26 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Figure_S1_of_Rifampin_use_in_acute_community-acquired_meningitis_in_intensive_care_units_the_French_retrospective_cohort_ACAM-ICU_study/4467848
Bacteria involved in 136 episodes of meningitis. Figure S2. Glasgow Outcome Scale scores for the groups of patients who did or did not receive rifampin for community-acquired meningitis. Figure S3. Glasgow Outcome Scale scores for the groups of patients who did or not receive early rifampin (within the first 24 h of hospitalization) or not for community-acquired meningitis. Table S1. Comparison of patient characteristics, severity at ICU admission, 9pt?>microbiological data, and therapeutic measures between survivors and non-survivors after ICU admission for pneumococcal meningitis (n=76). Table S2. Factors associated with ICU mortality for a cohort of 76 patients admitted for pneumococcal meningitis. (PDF 157 kb)